SEMAGLUTIDE
SEMAGLUTIDE (glucagon-like peptide-1 (GLP-1) receptor agonist)
Semaglutide is a medication used in combination with diet and exercise to reduce the risk of major cardiovascular events such as death, heart attack or stroke in adults already known to have existing heart disease and a form of obesity and to help anyone over the age of 12 years old with a documented history of obesity or adults that are overweight that have weight related medical problems that would like assistance to lose excess body weight and keep it off. Semaglutide exclusively targets the GLP-1 receptor agonist.
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone which is released in the gut in response to eating. One of roles of a GLP-1 is to prompt the body to produce more insulin which assists in reducing blood sugar levels. In higher amounts it also interacts with parts of the brain that suppress your appetite and signal you to feel full. Average weight loss with GLP-1 can vary but patients average 3 to 5 pounds a month with the injections alone. When used in conjunction with a healthy diet and exercise it can cause significant weight loss, research has shown that a person can lose an additional 6 to 9 pounds a month.
Semaglutide is used to assist patients with Type 2 Diabetes and obesity in losing weight while improving cardiovascular diseases. Semaglutide exclusively targets the GLP-1 receptor agonist. It gained approval by the US Food & Drug Administration in 2021 for the treatment of obesity.
When used in combination, semaglutide and pyridoxine support healthy weight loss and management, energy, and blood glucose balance. This combination is used to support treatment plans designed to help patients lose weight and reach and maintain a healthy weight. Pyridoxine helps reduce side effects while taking semaglutide, including nausea and vomiting. (evexias)
About Semaglutide/Pyridoxine
Semaglutide is an FDA-approved GLP1 agonist. Research has demonstrated that semaglutide supports glycemic control via improved Insulin secretion, and weight loss and management. Other data suggests
support for reduced risk of major cardiovascular events in type 2 diabetes patients. Semaglutide and pyridoxine, when used together, has been reported to help improve levels of vitamin B6 to support energy, reduce nausea, help decrease body fat, reduce weight, and support improvement in appetite suppression, blood sugar regulation, food cravings, and promotes improved renal function. (Evexias)
https://www.uclahealth.org/news/semaglutide-weight-loss-what-you-need-know